BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36122410)

  • 1. Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma.
    Welters C; Lammoglia Cobo MF; Stein CA; Hsu MT; Ben Hamza A; Penter L; Chen X; Buccitelli C; Popp O; Mertins P; Dietze K; Bullinger L; Moosmann A; Blanc E; Beule D; Gerbitz A; Strobel J; Hackstein H; Rahn HP; Dornmair K; Blankenstein T; Hansmann L
    Cancer Immunol Res; 2022 Nov; 10(11):1407-1419. PubMed ID: 36122410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune phenotypes and checkpoint molecule expression of clonally expanded lymph node-infiltrating T cells in classical Hodgkin lymphoma.
    Ballhausen A; Ben Hamza A; Welters C; Dietze K; Bullinger L; Rahn HP; Hartmann S; Hansmann ML; Hansmann L
    Cancer Immunol Immunother; 2023 Feb; 72(2):515-521. PubMed ID: 35947165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer.
    Penter L; Dietze K; Ritter J; Lammoglia Cobo MF; Garmshausen J; Aigner F; Bullinger L; Hackstein H; Wienzek-Lischka S; Blankenstein T; Hummel M; Dornmair K; Hansmann L
    Oncoimmunology; 2019; 8(6):e1586409. PubMed ID: 31069154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone Marrow.
    Hansmann L; Han A; Penter L; Liedtke M; Davis MM
    Cancer Immunol Res; 2017 Sep; 5(9):744-754. PubMed ID: 28768640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal rearrangement of the beta-T cell receptor gene in multiple myeloma.
    Berenson J; Lichtenstein A
    Leukemia; 1989 Feb; 3(2):133-6. PubMed ID: 2536128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1 Blockade Reinvigorates Bone Marrow CD8
    Kwon M; Kim CG; Lee H; Cho H; Kim Y; Lee EC; Choi SJ; Park J; Seo IH; Bogen B; Song IC; Jo DY; Kim JS; Park SH; Choi I; Choi YS; Shin EC
    Clin Cancer Res; 2020 Apr; 26(7):1644-1655. PubMed ID: 31941832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cells in multiple myeloma display features of exhaustion and senescence at the tumor site.
    Zelle-Rieser C; Thangavadivel S; Biedermann R; Brunner A; Stoitzner P; Willenbacher E; Greil R; Jöhrer K
    J Hematol Oncol; 2016 Nov; 9(1):116. PubMed ID: 27809856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal cytotoxic T cells in myeloma.
    Sze DM; Brown RD; Yuen E; Gibson J; Ho J; Raitakari M; Basten A; Joshua DE; Fazekas de St Groth B
    Leuk Lymphoma; 2003 Oct; 44(10):1667-74. PubMed ID: 14692517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The feature of distribution and clonality of TCR γ/δ subfamilies T cells in patients with B-cell non-Hodgkin lymphoma.
    Wang L; Xu M; Wang C; Zhu L; Hu J; Chen S; Wu X; Li B; Li Y
    J Immunol Res; 2014; 2014():241246. PubMed ID: 24963496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of TCR Repertoire and PD-1 Expression in Decidual and Peripheral CD8
    Morita K; Tsuda S; Kobayashi E; Hamana H; Tsuda K; Shima T; Nakashima A; Ushijima A; Kishi H; Saito S
    Front Immunol; 2020; 11():1082. PubMed ID: 32582176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry.
    Ben Hamza A; Welters C; Stadler S; Brüggemann M; Dietze K; Brauns O; Brümmendorf TH; Winkler T; Bullinger L; Blankenstein T; Rosenberger L; Leisegang M; Kammertöns T; Herr W; Moosmann A; Strobel J; Hackstein H; Dornmair K; Beier F; Hansmann L
    Blood; 2024 Apr; 143(14):1365-1378. PubMed ID: 38277625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation.
    Hirokawa M; Matsutani T; Saitoh H; Ichikawa Y; Kawabata Y; Horiuchi T; Kitabayashi A; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB; Sawada K
    Bone Marrow Transplant; 2002 Dec; 30(12):915-23. PubMed ID: 12476285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T cell repertoires correlate with pathogenesis of chronic idiopathic thrombocytopenic purpura].
    Zhu X; Zhu P; Guo XL
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3316-22. PubMed ID: 16409835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing.
    Risitano AM; Maciejewski JP; Green S; Plasilova M; Zeng W; Young NS
    Lancet; 2004 Jul 24-30; 364(9431):355-64. PubMed ID: 15276395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
    Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ;
    Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
    J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status.
    Giannotta C; Castella B; Tripoli E; Grimaldi D; Avonto I; D'Agostino M; Larocca A; Kopecka J; Grasso M; Riganti C; Massaia M
    Front Immunol; 2022; 13():1073227. PubMed ID: 36605214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden.
    Halapi E; Werner A; Wahlström J; Osterborg A; Jeddi-Tehrani M; Yi Q; Janson CH; Wigzell H; Grunewald J; Mellstedt H
    Eur J Immunol; 1997 Sep; 27(9):2245-52. PubMed ID: 9341766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion.
    Orsini E; Alyea EP; Schlossman R; Canning C; Soiffer RJ; Chillemi A; Neuberg D; Anderson KC; Ritz J
    Bone Marrow Transplant; 2000 Mar; 25(6):623-32. PubMed ID: 10734296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.